Navigation Links
Arno Therapeutics Announces Second Quarter 2008 Financial Results
Date:8/18/2008

p>

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY (DEFICIENCY)

Preferred stock, $0.0001 par value:

20,000,000 shares authorized,

0 shares issued and outstanding

at June 30, 2008 and December 31, 2007 - -

Common stock, $0.0001 par value:

80,000,000 shares authorized,

20,392,024 shares issued and

outstanding at June 30, 2008 and

9,968,797 shares issued and

outstanding at December 31, 2007 2,039 997

Additional paid-in capital 23,852,225 102,003

Deficit accumulated during the

development stage (11,200,103) (3,730,590)

TOTAL STOCKHOLDERS' EQUITY (DEFICIENCY) 12,654,161 (3,627,590)

TOTAL LIABILITIES AND STOCKHOLDERS'

EQUITY (DEFICIENCY) $14,594,767 $1,784,234

ARNO THERAPEUTICS, INC.

(A DEVELOPMENT STAGE COMPANY)

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

For the For the For the For the

Three Three Six Six

Months Months Months Months

Ended Ended Ended Ended

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

OPERATING EXPENSES

Research and

development $2,101,862 $401,402 $5,289,044 $612,199

General and

administrative 741,112 75,512 1,173,377 133,540

Total Operating

Expenses 2,842,974 476,914 6,462,421 745,739

LOSS FROM OPERATIONS (2,842,97
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, ... as Sales & Marketing Director. , With more than 25 years of ... for reinforcing Tronics’ business development activities worldwide. He brings to the company his ...
(Date:7/30/2015)... -- According to a new market research ... PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by ... End Users - Global Forecast to 2020", published by ... 2,107.99 million by 2020 from USD 1,034.93 million in ... Browse more than 75 market ...
(Date:7/30/2015)... 30, 2015   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... that its strategic partner VetStem Biopharma, Inc. has ... of AT-016, an adipose-derived allogeneic stem cell product ... osteoarthritis pain in dogs. The double-blinded, ...
(Date:7/30/2015)... 2015  With over 60,000 customers across the globe, ISN improves the efficiency and ... with more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers ... Headquartered in Dallas, TX , ISN has ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... an update on the progress of Sangamo,s ZFP Therapeutic® development ... 11:00 am ET on Tuesday, November 15, 2011 at the ... held in New York City. The presentation will ...
... Nov. 8, 2011 Accuray Incorporated (Nasdaq: ARAY), ... today financial results for the first quarter of fiscal ... June 10, 2011, Accuray completed the acquisition of TomoTherapy. ... reflect the consolidation of both Accuray and TomoTherapy.  Non-GAAP ...
... Santo VC GmbH has acquired a EUR 20 ... has also secured an option for further capital increases in ... increased its existing investment in AFFiRiS by EUR 5 million ... has an additional EUR 25 million in   equity at ...
Cached Biology Technology:Sangamo BioSciences Announces Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference 2Accuray Announces Results for First Quarter Fiscal 2012 2Accuray Announces Results for First Quarter Fiscal 2012 3Accuray Announces Results for First Quarter Fiscal 2012 4Accuray Announces Results for First Quarter Fiscal 2012 5Accuray Announces Results for First Quarter Fiscal 2012 6Accuray Announces Results for First Quarter Fiscal 2012 7Accuray Announces Results for First Quarter Fiscal 2012 8Accuray Announces Results for First Quarter Fiscal 2012 9Accuray Announces Results for First Quarter Fiscal 2012 10Accuray Announces Results for First Quarter Fiscal 2012 11AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 2AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 3AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 4
(Date:7/23/2015)... , July 23, 2015 Research and ... of the "Global Outlook of the Biometrics ... The global biometrics market is ... and commercial applications owing to the uptake of ... a transformation that enhances the growth of biometrics ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 07, 2015 ... announced the addition of the "Biometrics for ... Forecasts 2015-2020" report to their offering. ... major contributor to this growth and the forecast ... billion in revenue for companies involved in delivering ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... has provided the first detailed look at the internal head ... fossil animal that represents an important intermediate step in the ... Results of the study, published in this week,s issue ... from aquatic to terrestrial lifestyle involved complex changes not only ...
... dine on fish, shrimp, and mollusks, they are ... New genetic research carried out by Eugenia Naro-Maciel, ... Biodiversity and Conservation at the American Museum of ... the evolutionary relationships among all seven sea turtle ...
... of cells can be detected in a mineral likely ... obtained using a technique developed at the U.S. Department ... choose Martian surface samples with the most promise for ... tiny bits of mineral and looks for chemical signatures ...
Cached Biology News:Details of evolutionary transition from fish to land animals revealed 2Revealing the evolutionary history of threatened sea turtles 2Sensitive laser instrument could aid search for life on Mars 2Sensitive laser instrument could aid search for life on Mars 3